Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
   
Ask the Experts About

Understanding Your LabsUnderstanding Your Labs
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


Treatment Success
Jun 18, 2005

I have been diagnosed with Hep C genotype 3a. My liver enzymes have been running 5 to 6 times high normal and my viral load is >7million. I hope to begin my first TX experience within months using pegylated interferon plus ribavirin. I am a 57 y. o. male and may have been first infected more than 30 years ago. Can you tell me what the prognosis of the above TX might be for me--what the percentage of TX success might be for my situation?

Response from Dr. Holodniy

People with genotypes 2 or 3 have a higher sustained response rate (60-70%) to treatment than genotype 1 (20-30%). A sustained response is defined as an undetectable viral load 6-12 months after finishing treatment. However other factors such as stage of fibrosis or cirrhosis, viral load, age, gender, duration of disease and excessive alcohol consumption also influence treatment response.



Previous
Radical Changes in Counts
Next
HBV and HAV inmune for ever?

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement